Liaoning Chengda Biotechnology Co Ltd banner

Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 25.63 CNY -0.74% Market Closed
Market Cap: ¥10.7B

Wall Street
Price Targets

Price Targets Summary
Liaoning Chengda Biotechnology Co Ltd

There are no price targets for Liaoning Chengda Biotechnology Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Liaoning Chengda Biotechnology Co Ltd Competitors:
Price Targets
BIOX
Bioceres Crop Solutions Corp
248% Upside
RCKT
Rocket Pharmaceuticals Inc
140% Upside
NN
NextNav Inc
27% Upside

Revenue
Forecast

6% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
6% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 11%.

Operating Income
Forecast

-1% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-1% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is -1%. The projected CAGR for the next 2 years is 22%.

Net Income
Forecast

-1% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-1% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is -1%. The projected CAGR for the next 2 years is 24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Liaoning Chengda Biotechnology Co Ltd's stock price target?
Not Available

Liaoning Chengda Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Liaoning Chengda Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 6%. The projected CAGR for the next 2 years is 11%.

What is Liaoning Chengda Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
22%

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is -1%. The projected CAGR for the next 2 years is 22%.

What is Liaoning Chengda Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
24%

For the last 11 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is -1%. The projected CAGR for the next 2 years is 24%.

Back to Top